Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion
July 24, 2017 at 05:22 AM EDT
Michael Brush does the math and says that could have funded the development of 15 to 20 drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|